In this study, they conducted a subgroup analysis of patients with HRV infection and found a significant increase in IFN-α in the group of patients treated with omalizumab, which may be a protective mechanism for viral-induced asthma exacerbations [81]. This evidence concerns the gene IFNA1 and asthma.